劉 嚴文

Medicine & Life Sciences

1. Atrial Fibrillation 27%
2. B7-H1 Antigen 15%
3. C-Reactive Protein 18%
4. Cardiac Myocytes 77%
5. Cardiovascular Diseases 18%
6. Cell- and Tissue-Based Therapy 46%
7. Chronic Renal Insufficiency 18%
8. Coronary Artery Disease 30%
9. Echocardiography 100%
10. Endocarditis 20%
11. Exercise 14%
12. Heart 32%
13. Heart Ventricles 21%
14. Human Embryonic Stem Cells 26%
15. Hypertension 30%
16. Immune Privilege 14%
17. Induced Pluripotent Stem Cells 22%
18. Left Atrial Function 14%
19. Left Ventricular Dysfunction 38%
20. Left Ventricular Function 42%
21. Mitral Valve Insufficiency 14%
22. Mortality 34%
23. Myocardial Infarction 24%
24. Myocardial Ischemia 15%
25. Myocardium 27%
26. Nanofibers 24%
27. Nanogels 15%
28. Peptides 18%
29. Primates 18%
30. Proprotein Convertases 14%
31. PTX3 protein 14%
32. Regeneration 22%
33. Renal Dialysis 54%
34. Right Ventricular Function 27%
35. Second Primary Neoplasms 15%
36. ST Elevation Myocardial Infarction 21%
37. Stem Cells 50%
38. Stroke 17%
39. Stroke Volume 59%
40. Swine 15%
41. Therapeutics 15%
42. Troponin T 31%
43. Tuberculous Pericarditis 18%